MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Novel oral anticoagulants (NOACs), which include direct thrombin inhibitor (dabigatran) and
direct factor Xa inhibitors (rivaroxaban, apixaban and edoxaban), are gaining popularity in …

In 2012, the Japan Gastroenterological Endoscopy Society published “Guidelines for
Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment” …

Diese interdisziplinäre Leitlinie unter Leitung der DGVS und Beteiligung benachbarter
Fachgesellschaften fasst die wichtigsten Aspekte zur Versorgung von Patienten mit …

Background & Aims There is controversy over whether use of non-vitamin K antagonist oral
anticoagulants (NOACs) associates with increased risk of major gastrointestinal bleeding …

Introduction: Gastrointestinal bleeding (GIB) is a major problem in patients on oral
anticoagulation therapy. This issue has become even more pressing since the introduction …

The relative risk of major gastrointestinal bleeding (GIB) among different direct oral
anticoagulants (DOACs) is debatable. Randomized controlled trials (RCTs) comparing …

Background and aims Delayed bleeding after gastric endoscopic submucosal dissection
(ESD) in patients receiving anticoagulants remains an unpreventable adverse event …

Background Direct oral anticoagulants are increasingly used for a wide range of indications.
However, data are conflicting about the risk of major gastrointestinal bleeding with these …

The increase in incidence of colonic diverticular bleeding is relative to an age-related rise in
the incidence of colonic diverticulosis and use of antithrombotic medication. However, risk …